New Faces Will Lead Office Of Regulatory Affairs As Two Top Officials Depart
Executive Summary
The face of FDA's Office of Regulatory Affairs will undergo a major change as two senior leaders leave the office responsible for managing inspections and enforcement activity
You may also be interested in...
FDA China Office Will Be Test Of International Diplomacy, Intra-Agency Politics
FDA's opening of a China Office will be an early test of how the agency handles the challenges of globalization, not only in working with foreign governments, but in restructuring itself to operate on a world-wide footing
FDA China Office Will Be Test Of International Diplomacy, Intra-Agency Politics
FDA's opening of a China Office will be an early test of how the agency handles the challenges of globalization, not only in working with foreign governments, but in restructuring itself to operate on a world-wide footing
FDA’s Price Tag For Foreign Facility Inspections Tops $225 Million
Biennial inspections of all foreign pharmaceuticals facilities would require FDA to spend an additional $225 million per year, according to CDER Director Janet Woodcock